Intestinal fluid secretion and osmotic fluid retention

Intestinal fluid secretion and osmotic fluid retention refer to the physiological and pathophysiological processes governing the movement of water and electrolytes across the intestinal epithelium [1]. Under normal conditions, the gut maintains a delicate balance between secretion and absorption to facilitate digestion and nutrient uptake; however, in disease states like secretory diarrhea, this balance is disrupted by the overactivation of chloride channels such as the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) [1][2]. Osmotic retention occurs when unabsorbed solutes in the intestinal lumen draw water out of the body via osmosis, a hallmark of malabsorption syndromes or the use of osmotic laxatives [3]. Pharmacological interventions typically target specific molecular entities involved in these processes, such as the Sodium-Hydrogen Exchanger 3 (NHE3) or Calcium-Activated Chloride Channels (CaCC), to restore fluid balance and prevent dehydration [2][4]. Understanding these mechanisms is vital for developing treatments for conditions ranging from infectious cholera to chronic inflammatory bowel diseases [1][5]. Sources: [1] Nemeth V, Pfleghaar N. Diarrhea. StatPearls [Internet]. 2023; [2] Field M. J Clin Invest. 2003;111(7):931-943; [3] Hammer HF, Hammer J. Sleisenger and Fordtran's Gastrointestinal and Liver Disease. 2020; [4] Thiagarajah JR, et al. Nat Rev Gastroenterol Hepatol. 2015;12(8):437-47; [5] Barrett KE, Keely JP. Annu Rev Physiol. 2000;62:535-72.

Other names

Secretory diarrheaOsmotic diarrheaIntestinal fluid transportFluid malabsorptionIntestinal electrolyte transport

Drugs modulate these processes by targeting specific molecular entities such as the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR), Sodium-Hydrogen Exchanger 3 (NHE3), Calcium-Activated Chloride Channels (CaCC), or Opioid receptors to either inhibit excessive secretion or promote the absorption of fluids and electrolytes [1][2].